Acid inhibitory medication and risk of gastric and oesophageal cancer
- PMID: 17047103
- PMCID: PMC1860103
- DOI: 10.1136/gut.2006.103283
Acid inhibitory medication and risk of gastric and oesophageal cancer
Abstract
What are the long term effects of acid suppressive medication on the risk of gastric and oesophageal cancer?
Conflict of interest statement
Conflict of interest: None declared.
Comment on
-
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.Gut. 2006 Nov;55(11):1538-44. doi: 10.1136/gut.2005.086579. Epub 2006 Jun 19. Gut. 2006. PMID: 16785284 Free PMC article.
References
-
- Comfort M W. Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance. Ann Intern Med 1951341331–1347. - PubMed
-
- Comfort M W, Kelsey M P, Berkson J. Gastric acidity before and after the development of carcinoma of the stomach. J Natl Cancer Inst 19477367–373. - PubMed
-
- Lagergren J, Bergstrom R, Lindgren A.et al Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New Engl J Med 1999340825–831. - PubMed
-
- Chow W H, Finkle W D, McLaughlin J K.et al The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995274474–477. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical